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background:  Although an episode of ventricular tachycardia and fibrillation (VT/VF), which can cause cardiac collapse, during the acute 
phase of acute myocardial infarction (AMI) was associated with worse outcomes in the pre-percutaneous coronary intervention (PCI) era, 
prognostic significance of VT/VF documented during acute phase is not fully elucidated in the PCI era.
Methods:  A total of 4,283 consecutive patients, who were registered to the Osaka Acute Coronary Insufficiency Study (OACIS) between 
1998 and 2011, were hospitalized within 12 hours of symptom onset and underwent emergent PCI, were studied. Acute phase VT/VF was 
defined as 3 or more consecutive ventricular premature complexes and/or VF within the first 7 hospital days.
results:  Acute phase VT/VF occurred in 997 (23.3%) patients. Factors associated with acute phase VT/VF were absence of diabetes 
mellitus, Killip class of ≥ II, left main or right coronary artery lesions, and peak creatine kinase of ≥ 3000 IU/l. In-hospital mortality rate and 
risk was significantly higher in patients with acute phase VT/VF than those without (14.6% vs. 4.3%, adjusted HR=1.83, 95%CI=1.27-2.60, 
p=0.0013). During a median follow-up period of 1658 days, there was no significant difference in mortality between the groups among 
overall patients after discharge (adjusted HR=1.26, 95%CI=0.91-1.70, p=0.16). In sub-group analyses, acute phase VT/VF was associated 
with an increased risk of mortality after discharge in high risk patients stratified by the Global Registry of Acute Coronary Events (GRACE) 
risk score of >=115 (adjusted HR=1.60, 95%CI=1.10-2.27, p=0.0014), but not in intermediate- and low- risk patients.
Conclusion:  Even in the PCI era, episodes of acute phase VT/VF remained a risk factor for in-hospital mortality in STEMI patients. 
However, impact of acute phase VT/VF on long-term mortality was limited to the high risk patients, once discharged alive.
